MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1007/s40620-025-02397-0

Медицинская библиотека · Journal of nephrology · 2025

Sustained renal response with belimumab in children with new-onset lupus nephritis.

Wang Ren, Sun Tao, Shi Zhuo, Fang Xiang, Yang Xiao, Zhou Yu, Kuang Qianhuining, Yao Jun, Wang Jingjing, Zhang ZhiQiang, Xia Zhengkun, Gao Chunlin, Zhang Pei

СтатьяПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

BACKGROUND

Belimumab is approved for treating systemic lupus erythematosus (SLE) in children over 5 years old; however, its efficacy and safety in pediatric SLE patients require further validation. This study aimed to evaluate the impact of belimumab on the long-term cumulative probability of sustained renal response and disease flare in children with lupus nephritis (LN), to inform clinical decision-making.

METHODS

We included a total of 96 children with LN in our study. The patients were part of a prospective cohort study and were divided into two groups: belimumab group (68 cases) and standard treatment (group (28 cases). We compared remission rates, flare rates, and adverse event incidence between these two groups.

RESULTS

After 152 weeks of follow-up, belimumab increased the renal response and complete renal response rates by 16.7% [odds ratios (OR) = 5.38 (1.33, 15.12)] and 24.7% [OR = 2.74 (1.04, 7.19)]. Belimumab significantly reduced the risk of LN flare, with a 46.2% lower flare rate in the belimumab group compared to the standard treatment group. There was no significant difference in long-term cumulative probability of complete remission between the belimumab and standard treatment groups (P = 0.081), and the standard treatment group had a higher flare rate (P = 0.004).

CONCLUSIONS

Adding belimumab to standard treatment may effectively maintain long-term kidney function and reduce LN flares, making it an effective and safe biologic agent.

Для цитирования: Wang Ren, Sun Tao, Shi Zhuo, Fang Xiang, Yang Xiao, Zhou Yu, Kuang Qianhuining, Yao Jun, Wang Jingjing, Zhang ZhiQiang, Xia Zhengkun, Gao Chunlin, Zhang Pei. Sustained renal response with belimumab in children with new-onset lupus nephritis.. Journal of nephrology. 2025. DOI: 10.1007/s40620-025-02397-0.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.